Skip to main content
Premium Trial:

Request an Annual Quote

Bruker, Kiestra Ink Co-marketing Pact for Microbiology Mass Spec System

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker Daltonics and Kiestra Lab Automation said today that they have expanded a co-marketing and cross-selling partnership covering the use of their technologies in microbiology laboratories.

The companies have also signed a research and development agreement to integrate Bruker's MALDI Biotyper and Kiestra’s MalditofA, an automatic colony picker.

The MALDI Biotyper classifies microorganisms through proteomic fingerprinting via high-throughput MALDI-TOF mass spectrometry while the MalditofA is used to automatically transfer a colony to the target plate in order to prevent mismatches.

"Each of our technologies alone has been quite successful already, and in combination they could change the way microbiology is performed in many routine labs," said Wolfgang Pusch, vice president for clinical research solutions and in vitro diagnostics at Bruker Daltonics. "Both technologies integrated together will help microbiology laboratories to perform their important tasks faster and better, despite a predicted shortage in experienced laboratory staff."

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.